IL6 and metastatic neoplasm: In prostate cancer, the levels of serum IL-6 range from 1.5–2.2 pg/mL in localized and locally invaded tumors, which is well below the serum levels reported (~100 pg/mL) when metastatic disease ensues [33, 34].